References
- Shapiro-Mendoza CK, Lackritz EM. Epidemiology of late and moderate preterm birth. Semin Fetal Neonat Med. 2012;17:120–125.
- Ramachandrappa A, Jain L. Health issues of the late preterm infant. Pediatr Clin North Am. 2009;56:565–577.
- Bhutani VK, Wong RJ, Stevenson DK. Hyperbilirubinemia in preterm neonates. Clin Perinatol. 2016;43:215–232.
- Maisels MJ, Watchko JF, Bhutani VK, et al. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol. 2012;32:660–664.
- Lozar-Krivec J, Bratanic B, Paro-Panjan D. The role of carboxyhemoglobin measured with CO-oximetry in the detection of hemolysis in newborns with ABO alloimmunization. J Matern Fetal Neonatal Med. 2016;29:452–456.
- Stevenson DK, Vreman HJ, Wong RJ, et al. Carbon monoxide and bilirubin production in neonates. Semin Perinatol. 2001;25:85–93.
- Ananth CV, Friedman AM, Gyamfi-Bannerman C. Epidemiology of moderate preterm, late preterm and early term delivery. Clin Perinatol. 2013;40:601–610.
- American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.
- Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6–14.
- Brown AK, Kim MH, Wu PY, et al. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics. 1985;75:393–400.
- Kaplan M, Hammerman C, Vreman HJ, et al. Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates. J Pediatr. 2010;157:772–777.
- Kaplan M, Na'amad M, Kenan A, et al. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers. Pediatrics. 2009;123:e132–e137.
- Christensen RD, Yaish HM. Hemolysis in preterm neonates. Clin Perinatol. 2016;43:233–240.
- Javier MC, Krauss A, Nesin M. Corrected end-tidal carbon monoxide closely correlates with the corrected reticulocyte count in coombs’ test-positive term neonates. Pediatrics. 2003;112:1333–1337.
- Uetani Y, Nakamura H, Okamoto E, et al. Carboxyhemoglobin measurements in the diagnosis of ABO hemolytic disease. Acta Paediatr Jpn. 1989;31:71–76.
- Buonocore G, Berti D, Cito G, et al. Moderately increased hemolysis in newborn infants with hyperbilirubinemia of unknown etiology. Biol Neonate. 1983;44:251–256.
- Kaplan M, Hammerman C, Renbaum P, et al. Differing pathogenesis of perinatal bilirubinemia in glucose-6-phosphate dehydrogenase-deficient versus-normal neonates. Pediatr Res. 2001;50:532–537.
- Owens EO. Endogenous carbon monoxide production in disease. Clin Biochem. 2010;43:1183–1188.
- Woodgate P, Jardine LA. Neonatal jaundice: phototherapy. BMJ Clin Evid. 2015;05:319–339.